<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-id journal-id-type="iso-abbrev">Trials</journal-id><journal-title-group><journal-title>Trials</journal-title></journal-title-group><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29310710</article-id><article-id pub-id-type="pmc">5759360</article-id><article-id pub-id-type="publisher-id">2414</article-id><article-id pub-id-type="doi">10.1186/s13063-017-2414-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Photobiomodulation using low-level laser therapy (LLLT) for patients with chronic traumatic brain injury: a randomized controlled trial study protocol</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Poiani</surname><given-names>Guilherme da Cruz Ribeiro</given-names></name><address><phone>(43)9.9924-7246</phone><email>comporta.saude@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Zaninotto</surname><given-names>Ana Luiza</given-names></name><address><email>ana.zaninotto@yahoo.com.br</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Carneiro</surname><given-names>Ana Maria Costa</given-names></name><address><email>amcostac@gmail.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Zangaro</surname><given-names>Renato Amaro</given-names></name><address><email>razangaro@gmail.com</email></address><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Salgado</surname><given-names>Afonso Shiguemi Inoue</given-names></name><address><email>afonsosisalgado@yahoo.com.br</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Parreira</surname><given-names>Rodolfo Borges</given-names></name><address><email>dolfo23@yahoo.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>de Andrade</surname><given-names>Almir Ferreira</given-names></name><address><email>alandrade.psnc@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Teixeira</surname><given-names>Manoel Jacobsen</given-names></name><address><email>manoelj@aclnet.com.br</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Paiva</surname><given-names>Wellingson Silva</given-names></name><address><email>wellingsonpaiva@yahoo.com.br</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0722</institution-id><institution-id institution-id-type="GRID">grid.11899.38</institution-id><institution>Division of Psychology at Hospital of Clinics, </institution><institution>University of Sao Paulo Medical School, </institution></institution-wrap>Sao Paulo, Brazil </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0722</institution-id><institution-id institution-id-type="GRID">grid.11899.38</institution-id><institution>Division of Neurosurgery, </institution><institution>University of Sao Paulo Medical School, </institution></institution-wrap>Av. Dr. Arnaldo, 455 - Cerqueira C&#x000e9;sar, 01246-903 Sao Paulo, SP Brazil </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8753 0012</institution-id><institution-id institution-id-type="GRID">grid.461985.7</institution-id><institution>Institute of Biomedical Engineering, </institution><institution>Anhembi Morumbi University, </institution></institution-wrap>Sao Jose dos Campos, Sao Paulo, Brazil </aff><aff id="Aff4"><label>4</label>Salgado Institute of Integral Health; School of Postural and Manual Therapy, Londrina, Parana Brazil </aff><aff id="Aff5"><label>5</label>Center for Innovation, Technology and Education &#x02013; CTE, Sao Jose dos Campos, Sao Paulo, Brazil </aff></contrib-group><pub-date pub-type="epub"><day>8</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>8</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>19</volume><elocation-id>17</elocation-id><history><date date-type="received"><day>2</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>15</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Photobiomodulation using low-level laser therapy (LLLT) has been tested as a new technique to optimize recovery of patients with traumatic brain injury (TBI). The aim of this study is to evaluate inhibitory attentional control after 18 sessions of active LLLT and compare with the placebo group (sham LLLT). Our exploratory analysis will evaluate the efficacy of the active LLLT on verbal and visuospatial episodic memory, executive functions (working memory, verbal and visuospatial fluency, attentional processes), and anxiety and depressive symptoms compared to the sham group.</p></sec><sec><title>Methods/Design</title><p id="Par2">A randomized double-blinded trial will be made in 36 patients with moderate and severe TBI. The active LLLT will use an optical device composed of LEDs emitting 632&#x000a0;nm of radiation at the site with full potency of 830&#x000a0;mW. The cranial region with an area of 400&#x000a0;cm<sup>2</sup> will be irradiated for 30&#x000a0;min, giving a total dose per session of 3.74&#x000a0;J/cm<sup>2</sup>. The sham LLLT group contains only an LED device with power&#x02009;&#x0003c;&#x02009;1&#x000a0;mW, only serving to simulate the irradiation. Each patient will be irradiated three times per week for six weeks, totaling 18 sessions. Neuropsychological assessments will be held one week before the beginning of the sessions, after one week, and three months after the end of LLLT sessions. Memory domain, attention, executive functioning, and visual construction will be evaluated, in addition to symptoms of depression, anxiety, and social demographics.</p></sec><sec><title>Discussion</title><p id="Par3">LLLT has been demonstrated as a safe and effective technique in significantly improving the memory, attention, and mood performance in healthy and neurologic patients. We expect that our trial can complement previous finds, as an effective low-cost therapy to improve cognitive sequel after TBI.</p></sec><sec><title>Trial registration</title><p id="Par4">ClinicalTrials.gov, <ext-link ext-link-type="uri" xlink:href="https://tinyurl.com/Trialsregistration">NCT02393079</ext-link>. Registered on 20 February 2015.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Traumatic brain injury</kwd><kwd>Cognition</kwd><kwd>Memory</kwd><kwd>Depression</kwd><kwd>Anxiety</kwd><kwd>Photobiomodulation</kwd><kwd>Rehabilitation</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><sec id="Sec2"><title>Epidemiology</title><p id="Par38">Traumatic brain injury (TBI) is one of the main problems in the public health system due to its magnitude and clinical and social consequences [<xref ref-type="bibr" rid="CR1">1</xref>]. It is the main cause of disability in young adults, with an estimated 2 million visits to emergency services in the United States in 2009 [<xref ref-type="bibr" rid="CR2">2</xref>]. In low-income countries, the rate of TBI, especially due to motor vehicles, are&#x02009;&#x0003e;&#x02009;80% of all cases, leading to higher costs and disabilities [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. In Brazil, the incidence of TBI is 65.6/100,000 inhabitants per year; however, this incidence appears to be underestimated due to the lack of methodology or inadequate documentation of medical records [<xref ref-type="bibr" rid="CR5">5</xref>].</p></sec><sec id="Sec3"><title>Clinical and functional problems due to TBI</title><p id="Par39">TBI is an alteration in brain function, or other evidence of brain pathology, caused by an external cause [<xref ref-type="bibr" rid="CR6">6</xref>]. The trauma can result in long-lasting disability, even in people with mild TBI [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par40">Long-term neurological and cognitive deficits are expected, including a variety of cognitive impairments, such as in learning, executive function including working memory [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>] and verbal fluency [<xref ref-type="bibr" rid="CR10">10</xref>], reaction time, perceptual organization [<xref ref-type="bibr" rid="CR11">11</xref>], attention, verbal and visual episodic memory [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>], depression, anxiety [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], fatigue, sleep disorders, and attention deficit [<xref ref-type="bibr" rid="CR15">15</xref>]. Those symptoms are associated with loss of functionality,absence from work, and personal and social privations [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p></sec><sec id="Sec4"><title>Rationale for the photobiomodulation using low-level laser therapy (LLLT) in patients with TBI</title><p id="Par41">Considerable evidence has shown that the brain has an extensive ability of reorganization after damage [<xref ref-type="bibr" rid="CR18">18</xref>]. Non-invasive brain stimulation (NIBS) can modulate brain plasticity after trauma through increasing synaptic strength, modulating neurotransmitters, and modifying neural networks [<xref ref-type="bibr" rid="CR18">18</xref>&#x02013;<xref ref-type="bibr" rid="CR21">21</xref>]. LLLT is a technique of NIBS that the irradiation of specific infrared wavelengths is able to penetrate deeply into the brain [<xref ref-type="bibr" rid="CR22">22</xref>]. These effects produce many biological responses, such as affecting the forming of adenosine triphosphate (ATP), increasing deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), releasing nitric oxide (NO), cytochrome c oxidase (CCO), regulating reactive oxygen species (ROS), and modifying intracellular organelle membrane activity particularly in mitochondria, calcium flux, and stress proteins [<xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>]. LLLT produces a shift toward higher oxidation in the overall cell redox potential [<xref ref-type="bibr" rid="CR26">26</xref>] and briefly increases the level of ROS [<xref ref-type="bibr" rid="CR27">27</xref>]. This change in the redox state of the mitochondria regulates several transcription factors [<xref ref-type="bibr" rid="CR28">28</xref>]. These include redox factor-1 (Ref-1), cAMP response element (CREB), activator protein 1 (AP-1), p53, nuclear factor kappa B (NF-jB), hypoxia-inducible factor (HIF-1), and HIF-like factor [<xref ref-type="bibr" rid="CR28">28</xref>]. The activation and regulation of redox-sensitive genes and transcription factors are thought to be caused by ROS induced from LLLT [<xref ref-type="bibr" rid="CR27">27</xref>]. In turn, both ATP levels and blood flow increase, improving oxygenation found in damaged areas of the brain [<xref ref-type="bibr" rid="CR28">28</xref>]. In animal models, LLLT has been investigated as an alternative treatment for brain injury, increasing neurogenesis after TBI [<xref ref-type="bibr" rid="CR29">29</xref>] and showing a protective effect for stroke [<xref ref-type="bibr" rid="CR30">30</xref>] and benefits for acute ischemic stroke, acute myocardial infarction, injured peripheral nerves, and spinal cord injury [<xref ref-type="bibr" rid="CR31">31</xref>&#x02013;<xref ref-type="bibr" rid="CR33">33</xref>]. Previous studies showed the safety of photobiostimulation in humans [<xref ref-type="bibr" rid="CR34">34</xref>], including promising interventions for acute stroke [<xref ref-type="bibr" rid="CR34">34</xref>], TBI [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR35">35</xref>&#x02013;<xref ref-type="bibr" rid="CR37">37</xref>], and dementia [<xref ref-type="bibr" rid="CR38">38</xref>]. However, to date, just one open-label clinical trial studies the effect of LED therapy on improving cognitive function in patients with TBI [<xref ref-type="bibr" rid="CR37">37</xref>]. Likewise, no randomized controlled trial studied the short-term and long-term effects of LLLT on the cognition of closed TBI patients.</p></sec><sec id="Sec5"><title>Objective</title><p id="Par42">The aim of this study is to evaluate inhibitory attentional control after 18 sessions of active LLLT and compare with the placebo group (sham LLLT). Our exploratory analysis will evaluate verbal and visuospatial episodic memory, executive functions (working memory, verbal and visuospatial fluency, attentional processes), and anxiety and depressive symptoms.</p></sec></sec><sec id="Sec6"><title>Methods</title><sec id="Sec7"><title>Study design</title><p id="Par43">This is a prospective, multicenter, randomized, parallel placebo-controlled trial that will be conducted at the Clinics Hospital, University of S&#x000e3;o Paulo (HC-FMUSP) and Salgado Institute, Londrina, Brazil. The protocol is registered on clinicaltrials.org (number NCT02393079). The trial will follow the CONSORT (Consolidated Standards of Reporting Trials) guidelines as well as SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) guidelines (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> provides all information about patient enrollment, interventions, and follow-ups.<fig id="Fig1"><label>Fig. 1</label><caption><p>Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT): enrollment, assessment, interventions, and data collection. BDI-II: Beck Depression Inventory, 2<sup>nd</sup> edition; BAI: Beck Anxiety Inventory; TMT A and B: Test Trail Making form A and B; COWAT: Controlled Oral Word Association Test; SNL: Sequence of Numbers and Letters; DSST: Digit Symbol Substitution Test; RAVLT: Rey Auditory Verbal Learning Test</p></caption><graphic xlink:href="13063_2017_2414_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Flowchart of the LLLT study</p></caption><graphic xlink:href="13063_2017_2414_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec8"><title>Eligible participants</title><sec id="Sec9"><title>Inclusion criteria</title><p id="Par44">
<list list-type="bullet"><list-item><p id="Par45">Patients of both genders;</p></list-item><list-item><p id="Par46">Age range 18&#x02013;60 years;</p></list-item><list-item><p id="Par47">Glasgow Coma Scale (GCS)&#x02009;&#x02264;&#x02009;12 at admission in the emergency room;</p></list-item><list-item><p id="Par48">Computer tomography (CT) or magnetic resonance imaging (MRI) consistent with closed TBI, including intracranial hematoma, subdural hematoma, epidural hematoma, diffuse axonal injury, hemorrhagic contusion, and subarachnoid hemorrhage;</p></list-item><list-item><p id="Par49">Loss of consciousness&#x02009;&#x02265;&#x02009;30&#x000a0;min;</p></list-item><list-item><p id="Par50">Post-traumatic amnesia of&#x02009;&#x02265;&#x02009;24&#x000a0;h;</p></list-item><list-item><p id="Par51">Outpatients with&#x02009;&#x0003e;&#x02009;6&#x000a0;months TBI;</p></list-item><list-item><p id="Par52">Signed informed consent.</p></list-item></list>
</p></sec><sec id="Sec10"><title>Exclusion criteria</title><p id="Par53">
<list list-type="bullet"><list-item><p id="Par54">Metal implant or device in the brain or scalp;</p></list-item><list-item><p id="Par55">Uncontrolled epilepsy;</p></list-item><list-item><p id="Par56">Non-consent sign;</p></list-item><list-item><p id="Par57">Portuguese not their first language;</p></list-item><list-item><p id="Par58">Non-comprehension and/or not able to follow instructions.</p></list-item></list>
</p></sec><sec id="Sec11"><title>Recruitment</title><p id="Par59">The patients will be contacted and invited to participate before or after their regular appointment at the Neurotrauma Outpatient Clinics at the HC-FMUSP or by a contact list of provided by the acute Neurotrauma Inpatient Section at the HC-FMUSP. The patients will give verbal consent before attending their first consent visit.</p></sec></sec><sec id="Sec12"><title>Study intervention</title><sec id="Sec13"><title>Standard care</title><p id="Par60">All patients will keep their clinical follow-up at the Neurotrauma Outpatient Clinics at HC-FMUSP or at Salgado Institute, Brazil, independently of the study group assignment or decision of dropping out. A trained research nurse and a psychologist introduced the trial to patients informing them of the principles, objectives, and safety/harm. A trained physical therapist will also conduct and follow the patients along the trial.</p><p id="Par61">All information related to patients (i.e. data analysis, anthropometrical measures, reports, and other relevant information) will be stored in locked file cabinets in areas with limited access. These files will be identified with a code ID and only researchers of this study will have access to this information.</p></sec><sec id="Sec14"><title>LLLT intervention</title><p id="Par62">Two optical and identical devices (helmets) will be used for the intervention (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). For the active optical device, a helmet configured with 13 sets of LEDs at a 632-nm wavelength will distribute a total optical radiation of 830&#x000a0;mW over the skull surface. The skull area receiving irradiation is approximately 400&#x000a0;cm<sup>2</sup> during 30&#x000a0;min, in which the total expected dose per session is 3.74&#x000a0;J/cm<sup>2</sup>. However, only 3.1% of this energy reaches the gray matter [<xref ref-type="bibr" rid="CR39">39</xref>].<fig id="Fig3"><label>Fig. 3</label><caption><p><bold>a</bold> Two identical helmets, active and sham stimulation. <bold>b</bold> The inside view of the active LLLT helmet</p></caption><graphic xlink:href="13063_2017_2414_Fig3_HTML" id="MO3"/></fig></p><p id="Par63">The rationale follows: optimal wavelength penetration within biological tissues, occurs with a wavelength range of 600&#x02013;1000&#x000a0;nm [<xref ref-type="bibr" rid="CR40">40</xref>]. The inactive helmet (sham) contains only LEDs with power&#x02009;&#x0003c;&#x02009;1&#x000a0;mW, only serving to simulate the irradiation of the patient. All the patients will be submitted to 18 30-min LLLT sessions (active or sham condition), three times per week over six weeks. For safety, after the LLLT intervention, the patient will be asked about side effects between sessions.</p></sec><sec id="Sec15"><title>Neuropsychological assessment</title><p id="Par64">Patients will be assessed at baseline, one week after the end of the LLLT, and three months after the LLLT sessions. Each patient will follow the participation period as shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>.</p><p id="Par65">Instruments:<list list-type="bullet"><list-item><p id="Par66">Beck Depression Inventory (BDI-II), used to assess depressive symptoms, classified as minimal (0&#x02013;11 scores), mild (12&#x02013;19), moderate (20&#x02013;35), and severe (36&#x02013;63) [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>];</p></list-item><list-item><p id="Par67">Beck Anxiety Inventory (BAI), used to assess anxiety symptoms, classified as minimal (0&#x02013;7 scores), mild (8&#x02013;15), moderate (16&#x02013;25), and severe (26&#x02013;63) [<xref ref-type="bibr" rid="CR42">42</xref>];</p></list-item><list-item><p id="Par68">Trail Making Test A and B (TMT A and TMT B), used to measure attention, speed, and mental flexibility. In TMT A, the patient is instructed to draw a line from 1 to 2, 2 to 3, and so on. In TMT B, the patient switches between numbers and letters, drawing a line from 1 to A, A to 2, 2 to B, and so on. On both forms A and B, the patients perform a sample before the real test. The patient is instructed to perform as fast as he/she can [<xref ref-type="bibr" rid="CR43">43</xref>];</p></list-item><list-item><p id="Par69">Stroop Test - Version Victoria, measuring cognitive control with each person can maintain a goal in mind and suppress a habitual response in favor of a less familiar one. The interference effect is determining by calculating the extra time required to name colors (Card 3) in comparison to the time required to name colors in the control task (Card 1) [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>];</p></list-item><list-item><p id="Par70">Controlled Oral Word Association Test (COWAT), used to evaluate the spontaneous production of words under restricted search conditions (verbal association fluency). For the phonemic fluency task, the patient must provide orally as many words as possible beginning with the letters F, A, and S for 1&#x000a0;min for each letter. For the semantic fluency task, the patient is asked to produce as many animals&#x02019; names as possible within 1&#x000a0;min. The total correct is the sum of all admissible words for the semantic category [<xref ref-type="bibr" rid="CR43">43</xref>];</p></list-item><list-item><p id="Par71">Five-point test, this test requires preproduction of novel designs under time constraints (3&#x000a0;min). The score is calculated including the total number of unique designs and the number of repeated designs (perseverations) [<xref ref-type="bibr" rid="CR45">45</xref>];</p></list-item><list-item><p id="Par72">Symbol Digit Modalities Test (SDMT) oral version, the test is used to assess divided attention, visual scanning, tracking, and speed. The examiner records the numbers that correspond with symbols. The number of correct substitutions within the 90-s interval is the score of the task [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>];</p></list-item><list-item><p id="Par73">Rey Auditory Verbal Learning Test (RAVLT), measures immediate episodic memory, learning, susceptibility to interference, and recognition memory. A list of 15 nouns (list A) is read aloud to the patient, for five consecutive trials, each followed by a free-recall test. An interference list of 15 words (list B) is presented, followed by a free-recall test of that list. Immediately after this, delayed recall of list A is tested (Trial 6), and after 20&#x000a0;min (Trial 7), without further presentation of those words. The recognition is performed by presenting 50 words containing words from lists A, B, and new words, and the patient needs to identity the words from list A [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR48">48</xref>];</p></list-item><list-item><p id="Par74">Sequence Numbers and Letters (Wechsler subscale - WAIS-III), used to evaluate working memory, random numbers, and letters is presented orally to the patient and must be mentally organized and immediately reported to the examiner with the following rule: first the crescent numbers then the letters (in alphabetical order). In test difficulty increases the patients correctly perform the task [<xref ref-type="bibr" rid="CR49">49</xref>];</p></list-item><list-item><p id="Par75">Digit Span (DS) Forward and Backwards (WAIS-III), the DS assesses working memory. For the DS forward, the patient hears carefully a sequence of numbers and must repeat it immediately in the same sequence as previously presented. For the DS backwards, the patient must repeat the sequence inversely. In both conditions the number of numbers presented increases as the patient hits two corrects scores from the same span [<xref ref-type="bibr" rid="CR49">49</xref>];</p></list-item><list-item><p id="Par76">Rey-Osterrieth Complex Figure Test (ROCF), the purpose is to assess visual&#x02013;spatial constructional ability and visual memory. The patient is required to copy the ROCF, and after 3 and 30&#x000a0;min, a white sheet is given to the patient, and asked to draw the amount of information retained over time [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>].</p></list-item></list></p></sec></sec><sec id="Sec16"><title>Primary outcome</title><p id="Par77">
<list list-type="bullet"><list-item><p id="Par78">Inhibitory attentional control (time score) measured by Stroop test. The Stroop test is known to be an accurate assessment of executive function in mild to moderate TBI [<xref ref-type="bibr" rid="CR52">52</xref>].</p></list-item></list>
</p></sec><sec id="Sec17"><title>Secondary outcomes</title><p id="Par79">
<list list-type="bullet"><list-item><p id="Par80">Verbal and visuospatial episodic memory;</p></list-item><list-item><p id="Par81">Executive functions (working memory, verbal and visuospatial fluency, attentional processes);</p></list-item><list-item><p id="Par82">Anxiety and depressive symptoms.</p></list-item></list>
</p></sec><sec id="Sec18"><title>Sample size</title><p id="Par83">Based on the previous pilot study [<xref ref-type="bibr" rid="CR37">37</xref>] that analyzed the cognitive function of patients with TBI after repetitive sessions of RED/Near-infrared LED treatment. Considering the improvement on Stroop test of 1 standard deviation (SD) related to the baseline, the level of significance of 0.05 and the power of 80%, 16 patients per group was estimated. Considering the rate of 15% of drop-outs, we added two participants per group, ending with a total sample of 36.</p></sec><sec id="Sec19"><title>Randomization</title><p id="Par84">All eligible recruited patients will be randomly divided into two groups with a 1:1 ratio and blocks of four and six performed by the co-investigator through the randomization list (randomization.com). The randomization list will be kept in safe storage with the co-investigator responsible for the stimulation sessions. She will provide the allocation concealment assignment for the patients. No information about the assigned group will be given for the patient or to the research assessor.</p></sec><sec id="Sec20"><title>Blinding and allocation concealment</title><p id="Par85">Both helmets, the active and the sham, are identical in size, color, and weight. The active helmet activates the red light when plugged; however, the sham helmet cannot provide visible light. The patient is not able to see the light and there is no hit during the active stimulation that can suggest the type of intervention. The unblinded investigator is the person in charge of performing the stimulation. Both assessor researcher and patient will be blind for the type of intervention.</p><p id="Par86">During the study, telephone contact can be used to maintain patient adherence to the trial. This study involves the participation of a research committee not directly related to the allocation of the patients. They can remove the blinding if any relevant situation may rise involving any clinical condition, adverse event, or even abandonment of the patient.</p></sec><sec id="Sec21"><title>Safety considerations and adverse events</title><p id="Par87">Phase 1 trials and animal studies showed evidence related to the safety of the LLLT [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. Although there are few studies in clinical patients, no side effects were reported using photostimulation and LLLT [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR54">54</xref>&#x02013;<xref ref-type="bibr" rid="CR57">57</xref>]. For safety, the LLLT will be applied by a registered nurse or a trained clinician.</p></sec><sec id="Sec22"><title>Ethical approval and consent to participate</title><p id="Par88">The protocol was approved by CONEP Resolution 466/2012, which regulates scientific research involving human beings in Brazil. It follows the ethical principles of Declaration of Helsinki for medical research involving human subjects.</p></sec><sec id="Sec23"><title>Statistical analysis</title><p id="Par89">Intention-to-treat and per-protocol analyses will be performed for the primary and secondary outcomes. Missing data will be analyzed with regression imputation, considering the confounders (months of the trauma, years of age, schooling years, and depressive symptoms). Patients that did not receive 60% of the total stimulation will be considered non-adherent and analyzed as per-protocol.</p><p id="Par90">Means and standard deviation will be used to represent data with normal distribution and medians and quartiles to describe non-normally distributed data. Two-way ANOVA (2 groups&#x02009;&#x000d7;&#x02009;3 times) with repeated measures (for parametric variables) or the Kruskal&#x02013;Wallis test (for non-parametric variables) will be used for the analysis of the TLT effects obtained in the three timelines: baseline, one week, and three weeks after the intervention. The Bonferroni correction for multiple comparisons will be employed as a post-hoc test. The effect size will be calculated based on the difference between means of the pre-intervention and post-intervention evaluations and will be expressed with respective 95% confidence intervals. Parametric Student&#x02019;s t-test or a Mann&#x02013;Whitney <italic>U</italic> test for non-parametric data will be employed to assess between-group (active and sham helmet) differences in age, height, weight, and body mass index (BMI), time of TBI injury, level of education, and Glasgow Coma Scale at admission on the emergency room. For all effects, a <italic>p</italic> value&#x02009;&#x0003c;&#x02009;0.05 will be considered indicative of statistical significance. The data will be organized and tabulated using the Statistical Package for the Social Sciences (SPSSv.19.0).</p></sec></sec><sec id="Sec24"><title>Discussion</title><p id="Par91">The present study is designed to evaluate the effects of 18 sessions of LLLT over cognition, in patients with chronic moderate and severe TBI. Our primary hypothesis is that the sessions of active LLLT will improve attention (at least 1 SD) measured by Stroop test compared to the placebo group (sham LLLT). Our secondary hypothesis is that the active group will improve in all domains assessed by the neuropsychological battery, including cognition and mood, compared to placebo group.</p><p id="Par92">LLLT can modulate many biological effects penetrating the scalp into the brain [<xref ref-type="bibr" rid="CR25">25</xref>], playing a role improving the outcome of the patients in two different ways, depending on the stage of the trauma. In the acute phase after TBI, the initial neuronal injury occurs instantly and oftentimes causes irreversible damage to the central nervous system, due to impairment of neuronal cell functions, including mitochondria, and glia cells [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. The disruption of neuronal circuitry causes loss of connectivity between different areas of the brain and can negatively impact neural regeneration, leading to dysfunctional interactions. In the secondary stage after the trauma, other changes may occur, including release of neurotransmitters, decreased glucose utilization, lactic acid accumulation, reduced activity of ATP-reliant ion pumps, increased release of glutamate, Ca2&#x02009;+&#x02009;&#x02212;induced depolarization, and excitotoxicity [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR58">58</xref>].</p><p id="Par93">Previous studies showed improvement on cognition including attentional process and episodic memory after repetitive sessions of LLLT in patients with TBI [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. It seems that the LLLT decreases the inflammatory response, helping the neuroprotection after TBI. This process leads to increases on the ATP, cellular energy, and blood flow, decreasing the metabolic process. In summary, the LLLT seems to increase the intercellular synapses, acting as a possible treatment after acute and chronic TBI [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR59">59</xref>&#x02013;<xref ref-type="bibr" rid="CR61">61</xref>].</p><p id="Par94">Other studies reported the effects of the LLLT in another sample. Lampl et al. [<xref ref-type="bibr" rid="CR34">34</xref>] used the LLLT in patients with ischemic stroke and showed that infrared wavelength therapy was safe and effective in the experimental group compared to the control groups when treatment was started 24&#x000a0;h after the onset of stroke. Another study with psychiatric patients showed that seven (out of ten) patients with severe cases of depression and anxiety presented symptom remission after two weeks elapsed with four LLLT applications in the prefrontal region, which did not occur with the control group [<xref ref-type="bibr" rid="CR62">62</xref>]. Likewise, LLLT has been demonstrated as a safe and effective technique in significantly improving the memory, attention, and mood performance of healthy people [<xref ref-type="bibr" rid="CR63">63</xref>]. Overall, we expect that our trial can complement previous findings, as an effective low-cost therapy to improve cognitive sequel in patients with chronic TBI.</p></sec><sec id="Sec25"><title>Trial status</title><p id="Par95">The randomization of patients was started on January 2015. The inclusion of participants is ongoing, with 12 patients completing the assessment, four patients in the second assessment and two patients in the first assessment. We expect to conclude the study by 5 October 2018.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AP-1</term><def><p id="Par5">Activator protein 1</p></def></def-item><def-item><term>ATP</term><def><p id="Par6">Adenosine triphosphate</p></def></def-item><def-item><term>BAI</term><def><p id="Par7">Beck Anxiety Inventory</p></def></def-item><def-item><term>BDI-II</term><def><p id="Par8">Beck Depression Inventory II</p></def></def-item><def-item><term>BMI</term><def><p id="Par9">Body mass index</p></def></def-item><def-item><term>CCO</term><def><p id="Par10">Cytochrome c oxidase</p></def></def-item><def-item><term>CONEP</term><def><p id="Par11">National Commission for Research Ethics</p></def></def-item><def-item><term>CONSORT</term><def><p id="Par12">Consolidated Standards of Reporting Trials</p></def></def-item><def-item><term>COWAT</term><def><p id="Par13">Controlled Oral Word Association Test</p></def></def-item><def-item><term>CREB</term><def><p id="Par14">cAMP Response Element-Binding Protein</p></def></def-item><def-item><term>CT</term><def><p id="Par15">Computed tomography</p></def></def-item><def-item><term>DNA</term><def><p id="Par16">Deoxyribonucleic acid</p></def></def-item><def-item><term>DS</term><def><p id="Par17">Digit span</p></def></def-item><def-item><term>DSST</term><def><p id="Par18">Digit Symbol Substitution Test</p></def></def-item><def-item><term>GCS</term><def><p id="Par19">Glasgow Coma Scale</p></def></def-item><def-item><term>HIF-1</term><def><p id="Par20">Hypoxia inducible factor</p></def></def-item><def-item><term>LED</term><def><p id="Par21">Light emitting diode</p></def></def-item><def-item><term>LLLT</term><def><p id="Par22">Low-level laser therapy</p></def></def-item><def-item><term>MRI</term><def><p id="Par23">Magnetic resonance imaging</p></def></def-item><def-item><term>NF-j B</term><def><p id="Par24">Nuclear factor Kappa B</p></def></def-item><def-item><term>NIBS</term><def><p id="Par25">Non-invasive brain stimulation</p></def></def-item><def-item><term>NO</term><def><p id="Par26">Nitric oxide</p></def></def-item><def-item><term>RAVLT</term><def><p id="Par27">Rey Auditory Verbal Learning Test</p></def></def-item><def-item><term>RCT</term><def><p id="Par28">Randomized controlled trial</p></def></def-item><def-item><term>Ref-1</term><def><p id="Par29">Redox factor-1</p></def></def-item><def-item><term>RNA</term><def><p id="Par30">Ribonucleic acid</p></def></def-item><def-item><term>ROCF</term><def><p id="Par31">Rey-Osterrieth Complex Figure Test</p></def></def-item><def-item><term>ROS</term><def><p id="Par32">Reactive oxygen species</p></def></def-item><def-item><term>SDMT</term><def><p id="Par33">Symbol Digit Modalities Test</p></def></def-item><def-item><term>SPIRIT</term><def><p id="Par34">Standard Protocol Items: Recommendations for Interventional Trials</p></def></def-item><def-item><term>TBI</term><def><p id="Par35">Traumatic brain injury</p></def></def-item><def-item><term>TMT A and B</term><def><p id="Par36">Test Trail Making form A and B</p></def></def-item><def-item><term>WAIS III</term><def><p id="Par37">Wechsler Adult Intelligence Scale III</p></def></def-item></def-list></glossary><ack><p>The authors thank everyone involved in this research, including the employees, patients, and their families. The authors give special thanks to the Salgado Institute of Integral Health and to the neuromodulation group of HCFMUSP. The authors also thank Priscila Rodrigues and Cintya Hayashi for their help during the recruitment and neuropsychological evaluations.</p><sec id="FPar1"><title>Funding</title><p id="Par96">The author(s) received no financial support for the research, authorship, and/or publication of this manuscript.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par97">Not applicable.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>GCRP performed neuropsychological assessments, data collection, review of the literature, manuscript writing and revision. ALZ participated in conception and design of the study, carried out patient recruitment, designed the neuropsychological assessment battery, revised the manuscript and neuropsychological assessments. AMC performed TLT applications, data collection, and review of the literature. ASSI carried out data analysis and revised the manuscript. MJT conceived the study and revised the manuscript. MCLS revised the manuscript. RAZ conceived the study and revised the manuscript. RBP participated in TLT applications and revised the manuscript. WSP participated in conception and design of the study, manuscript writing, and its final approval. All authors have read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par98">This study was approved by Committee for Ethics in Research of Psychology HC-FMUSP (COSEPE), number 15/2014; and the Ethics Committee of Project Research Analysis of the Faculty of Medicine HC-FMUSP, process number 42092815.9.0000.0068. All patients were clearly informed about the procedures and were required to sign consent form before inclusion in the study.</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par99">Approved by all co-authors.</p></sec><sec id="FPar5"><title>Competing interests</title><p id="Par100">The authors declare that they have no competing interests.</p></sec><sec id="FPar6"><title>Publisher&#x02019;s Note</title><p id="Par101">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kushner</surname><given-names>DS</given-names></name><name><surname>Johnson-Greene</surname><given-names>D</given-names></name></person-group><article-title>Changes in cognition and continence as predictors of rehabilitation outcomes in individuals with severe traumatic brain injury</article-title><source>J Rehabil Res Dev.</source><year>2014</year><volume>51</volume><fpage>1057</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1682/JRRD.2014.01.0002</pub-id><pub-id pub-id-type="pmid">25436488</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coronado</surname><given-names>VG</given-names></name><name><surname>McGuire</surname><given-names>LC</given-names></name><name><surname>Sarmiento</surname><given-names>K</given-names></name><name><surname>Bell</surname><given-names>J</given-names></name><name><surname>Lionbarger</surname><given-names>MR</given-names></name><name><surname>Jones</surname><given-names>CD</given-names></name><etal/></person-group><article-title>Trends in traumatic brain injury in the U.S. and the public health response: 1995&#x02013;2009</article-title><source>J Safety Res</source><year>2012</year><volume>43</volume><fpage>299</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1016/j.jsr.2012.08.011</pub-id><pub-id pub-id-type="pmid">23127680</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peeters</surname><given-names>S</given-names></name><name><surname>Blaine</surname><given-names>C</given-names></name><name><surname>Vycheth</surname><given-names>I</given-names></name><name><surname>Nang</surname><given-names>S</given-names></name><name><surname>Vuthy</surname><given-names>D</given-names></name><name><surname>Park</surname><given-names>KB</given-names></name></person-group><article-title>Epidemiology of traumatic brain injuries at a major government hospital in Cambodia</article-title><source>World Neurosurg.</source><year>2017</year><volume>97</volume><fpage>580</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.wneu.2016.09.127</pub-id><pub-id pub-id-type="pmid">27773857</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamal</surname><given-names>VK</given-names></name><name><surname>Agrawal</surname><given-names>D</given-names></name><name><surname>Pandey</surname><given-names>RM</given-names></name></person-group><article-title>Epidemiology, clinical characteristics and outcomes of traumatic brain injury: Evidences from integrated level 1 trauma center in India</article-title><source>J Neurosci Rural Pract.</source><year>2016</year><volume>7</volume><fpage>515</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.4103/0976-3147.188637</pub-id><pub-id pub-id-type="pmid">27695230</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Almeida</surname><given-names>CER</given-names></name><name><surname>de Sousa</surname><given-names>JL</given-names></name><name><surname>Dourado</surname><given-names>JC</given-names></name><name><surname>Gontijo</surname><given-names>PA</given-names></name><name><surname>Dellaretti</surname><given-names>MA</given-names></name><name><surname>Costa</surname><given-names>BS</given-names></name></person-group><article-title>Traumatic brain injury epidemiology in Brazil</article-title><source>World Neurosurg.</source><year>2016</year><volume>87</volume><fpage>540</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.wneu.2015.10.020</pub-id><pub-id pub-id-type="pmid">26485419</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menon</surname><given-names>DK</given-names></name><name><surname>Schwab</surname><given-names>K</given-names></name><name><surname>Wright</surname><given-names>DW</given-names></name><name><surname>Maas</surname><given-names>AI</given-names></name></person-group><article-title>Demographics and Clinical Assessment Working Group of the International and Interagency Initiative Toward Common Data Elements for Research on Traumatic Brain Injury and Psychological Health. Position statement: definition of traumatic brain injury</article-title><source>Arch Phys Med Rehabil</source><year>2010</year><volume>91</volume><fpage>1637</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.apmr.2010.05.017</pub-id><pub-id pub-id-type="pmid">21044706</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corrigan</surname><given-names>JD</given-names></name><name><surname>Selassie</surname><given-names>AW</given-names></name><name><surname>Orman</surname><given-names>JA</given-names></name></person-group><article-title>The epidemiology of traumatic brain injury</article-title><source>J Head Trauma Rehabil.</source><year>2010</year><volume>25</volume><fpage>72</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1097/HTR.0b013e3181ccc8b4</pub-id><pub-id pub-id-type="pmid">20234226</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niogi</surname><given-names>SN</given-names></name><name><surname>Mukherjee</surname><given-names>P</given-names></name><name><surname>Ghajar</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>CE</given-names></name><name><surname>Kolster</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><etal/></person-group><article-title>Structural dissociation of attentional control and memory in adults with and without mild traumatic brain injury</article-title><source>Brain.</source><year>2008</year><volume>131</volume><fpage>3209</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/brain/awn247</pub-id><pub-id pub-id-type="pmid">18952679</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skandsen</surname><given-names>T</given-names></name><name><surname>Finnanger</surname><given-names>TG</given-names></name><name><surname>Andersson</surname><given-names>S</given-names></name><name><surname>Lydersen</surname><given-names>S</given-names></name><name><surname>Brunner</surname><given-names>JF</given-names></name><name><surname>Vik</surname><given-names>A</given-names></name></person-group><article-title>Cognitive impairment 3&#x000a0;months after moderate and severe traumatic brain injury: a prospective follow-up study</article-title><source>Arch Phys Med Rehabil.</source><year>2010</year><volume>91</volume><fpage>1904</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.apmr.2010.08.021</pub-id><pub-id pub-id-type="pmid">21112433</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaninotto</surname><given-names>AL</given-names></name><name><surname>Guirado</surname><given-names>VMD</given-names></name><name><surname>Baldivia</surname><given-names>B</given-names></name><name><surname>Nunes</surname><given-names>MD</given-names></name><name><surname>Amorim</surname><given-names>RL</given-names></name><name><surname>Teixeira</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Improvement of verbal fluency in patients with diffuse brain injury over time</article-title><source>Neuropsychiatr Dis Treat.</source><year>2014</year><volume>10</volume><fpage>1155</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">25028551</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>TL</given-names></name><name><surname>Zaninotto</surname><given-names>ALC</given-names></name><name><surname>Benute</surname><given-names>GG</given-names></name><name><surname>De Lucia</surname><given-names>MC</given-names></name><name><surname>Paiva</surname><given-names>WS</given-names></name><name><surname>Wagemans</surname><given-names>J</given-names></name><etal/></person-group><article-title>Perceptual organization deficits in traumatic brain injury patients</article-title><source>Neuropsychologia.</source><year>2015</year><volume>78</volume><fpage>142</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.neuropsychologia.2015.10.008</pub-id><pub-id pub-id-type="pmid">26455804</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaninotto</surname><given-names>AL</given-names></name><name><surname>Vicentini</surname><given-names>JE</given-names></name><name><surname>Solla</surname><given-names>DJF</given-names></name><name><surname>Silva</surname><given-names>TT</given-names></name><name><surname>Guirado</surname><given-names>VM</given-names></name><name><surname>Feltrin</surname><given-names>F</given-names></name><etal/></person-group><article-title>Visuospatial memory improvement in patients with diffuse axonal injury (DAI): a 1-year follow-up study</article-title><source>Acta Neuropsychiatrica.</source><year>2017</year><volume>29</volume><fpage>35</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1017/neu.2016.29</pub-id><pub-id pub-id-type="pmid">27725006</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinnunen</surname><given-names>KM</given-names></name><name><surname>Greenwood</surname><given-names>R</given-names></name><name><surname>Powell</surname><given-names>JH</given-names></name><name><surname>Leech</surname><given-names>R</given-names></name><name><surname>Hawkins</surname><given-names>PC</given-names></name><name><surname>Bonnelle</surname><given-names>V</given-names></name><etal/></person-group><article-title>White matter damage and cognitive impairment after traumatic brain injury</article-title><source>Brain.</source><year>2011</year><volume>134</volume><fpage>449</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1093/brain/awq347</pub-id><pub-id pub-id-type="pmid">21193486</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaninotto</surname><given-names>AL</given-names></name><name><surname>Vicentini</surname><given-names>JE</given-names></name><name><surname>Fregni</surname><given-names>F</given-names></name><name><surname>Rodrigues</surname><given-names>PA</given-names></name><name><surname>Botelho</surname><given-names>C</given-names></name><name><surname>de Lucia</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Updates and current perspectives of psychiatric assessments after traumatic brain injury: a systematic review</article-title><source>Front Psych.</source><year>2016</year><volume>7</volume><fpage>95</fpage></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinclair</surname><given-names>KL</given-names></name><name><surname>Ponsford</surname><given-names>JL</given-names></name><name><surname>Taffe</surname><given-names>J</given-names></name><name><surname>Lockley</surname><given-names>SW</given-names></name><name><surname>Rajaratnam</surname><given-names>SM</given-names></name></person-group><article-title>Randomized controlled trial of light therapy for fatigue following traumatic brain injury</article-title><source>Neurorehabil Neural Repair.</source><year>2014</year><volume>28</volume><fpage>303</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1177/1545968313508472</pub-id><pub-id pub-id-type="pmid">24213962</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esbjornsson</surname><given-names>E</given-names></name><name><surname>Skoglund</surname><given-names>T</given-names></name><name><surname>Mitsis</surname><given-names>MK</given-names></name><name><surname>Hofgren</surname><given-names>C</given-names></name><name><surname>Larsson</surname><given-names>J</given-names></name><name><surname>Sunnerhagen</surname><given-names>KS</given-names></name></person-group><article-title>Cognitive impact of traumatic axonal injury (TAI) and return to work</article-title><source>Brain Inj.</source><year>2013</year><volume>27</volume><fpage>521</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.3109/02699052.2012.743179</pub-id><pub-id pub-id-type="pmid">23472977</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naeser</surname><given-names>MA</given-names></name><name><surname>Saltmarche</surname><given-names>A</given-names></name><name><surname>Krengel</surname><given-names>MH</given-names></name><name><surname>Hamblin</surname><given-names>MR</given-names></name><name><surname>Knight</surname><given-names>JA</given-names></name></person-group><article-title>Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: two case reports</article-title><source>Photomed Laser Surg.</source><year>2011</year><volume>29</volume><fpage>351</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1089/pho.2010.2814</pub-id><pub-id pub-id-type="pmid">21182447</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>SS</given-names></name><name><surname>Zaninotto</surname><given-names>AL</given-names></name><name><surname>Neville</surname><given-names>IS</given-names></name><name><surname>Paiva</surname><given-names>WS</given-names></name><name><surname>Nunn</surname><given-names>D</given-names></name><name><surname>Fregni</surname><given-names>F</given-names></name></person-group><article-title>Clinical utility of brain stimulation modalities following traumatic brain injury: current evidence</article-title><source>Neuropsychiatr Dis Treat.</source><year>2015</year><volume>11</volume><fpage>1573</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">26170670</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>PB</given-names></name><name><surname>Hoy</surname><given-names>KE</given-names></name><name><surname>Maller</surname><given-names>JJ</given-names></name><name><surname>Herring</surname><given-names>S</given-names></name><name><surname>Segrave</surname><given-names>R</given-names></name><name><surname>McQueen</surname><given-names>S</given-names></name><etal/></person-group><article-title>Transcranial magnetic stimulation for depression after a traumatic brain injury: a case study</article-title><source>J ECT.</source><year>2011</year><volume>27</volume><fpage>38</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1097/YCT.0b013e3181eb30c6</pub-id><pub-id pub-id-type="pmid">20938348</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesniak</surname><given-names>M</given-names></name><name><surname>Polanowska</surname><given-names>K</given-names></name><name><surname>Seniow</surname><given-names>J</given-names></name><name><surname>Czlonkowska</surname><given-names>A</given-names></name></person-group><article-title>Effects of repeated anodal tDCS coupled with cognitive training for patients with severe traumatic brain injury: a pilot randomized controlled trial</article-title><source>J Head Trauma Rehabil.</source><year>2014</year><volume>29</volume><fpage>E20</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1097/HTR.0b013e318292a4c2</pub-id><pub-id pub-id-type="pmid">23756431</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villamar</surname><given-names>MF</given-names></name><name><surname>Portilla</surname><given-names>AS</given-names></name><name><surname>Fregni</surname><given-names>F</given-names></name><name><surname>Zafonte</surname><given-names>R</given-names></name></person-group><article-title>Noninvasive brain stimulation to modulate neuroplasticity in traumatic brain injury</article-title><source>Neuromodulation.</source><year>2012</year><volume>15</volume><fpage>326</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1111/j.1525-1403.2012.00474.x</pub-id><pub-id pub-id-type="pmid">22882244</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Ma</surname><given-names>HY</given-names></name><name><surname>Nioka</surname><given-names>S</given-names></name><name><surname>Chance</surname><given-names>B</given-names></name></person-group><article-title>Study of near infrared technology for intracranial hematoma detection</article-title><source>J Biomed Opt.</source><year>2000</year><volume>5</volume><fpage>206</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1117/1.429988</pub-id><pub-id pub-id-type="pmid">10938785</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antunes</surname><given-names>F</given-names></name><name><surname>Boveris</surname><given-names>A</given-names></name><name><surname>Cadenas</surname><given-names>E</given-names></name></person-group><article-title>On the mechanism and biology of cytochrome oxidase inhibition by nitric oxide</article-title><source>Proc Natl Acad Sci U S A.</source><year>2004</year><volume>101</volume><fpage>16774</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1073/pnas.0405368101</pub-id><pub-id pub-id-type="pmid">15546991</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khuman</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Carroll</surname><given-names>JD</given-names></name><name><surname>Donahue</surname><given-names>C</given-names></name><name><surname>Whalen</surname><given-names>MJ</given-names></name></person-group><article-title>Low-level laser light therapy improves cognitive deficits and inhibits microglial activation after controlled cortical impact in mice</article-title><source>J Neurotrauma.</source><year>2012</year><volume>29</volume><fpage>408</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1089/neu.2010.1745</pub-id><pub-id pub-id-type="pmid">21851183</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>YY</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Vecchio</surname><given-names>D</given-names></name><name><surname>de Arce</surname><given-names>VJ</given-names></name><name><surname>Huang</surname><given-names>SF</given-names></name><name><surname>Xuan</surname><given-names>W</given-names></name><etal/></person-group><article-title>Transcranial low level laser (light) therapy for traumatic brain injury</article-title><source>J Biophotonics.</source><year>2012</year><volume>5</volume><fpage>827</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1002/jbio.201200077</pub-id><pub-id pub-id-type="pmid">22807422</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karu</surname><given-names>TI</given-names></name><name><surname>Pyatibrat</surname><given-names>LV</given-names></name><name><surname>Kolyakov</surname><given-names>SF</given-names></name><name><surname>Afanasyeva</surname><given-names>NI</given-names></name></person-group><article-title>Absorption measurements of a cell monolayer relevant to phototherapy: Reduction of cytochrome c oxidase under near IR radiation</article-title><source>J Photochem Photobiol B Biol.</source><year>2005</year><volume>81</volume><fpage>98</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2005.07.002</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>ACH</given-names></name><name><surname>Arany</surname><given-names>PR</given-names></name><name><surname>Huang</surname><given-names>YY</given-names></name><name><surname>Tomkinson</surname><given-names>EM</given-names></name><name><surname>Sharma</surname><given-names>SK</given-names></name><name><surname>Kharkwal</surname><given-names>GB</given-names></name><etal/></person-group><article-title>Low-level laser therapy activates NF-kB via generation of reactive oxygen species in mouse embryonic fibroblasts</article-title><source>PloS One.</source><year>2011</year><volume>6</volume><fpage>e22453</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0022453</pub-id><pub-id pub-id-type="pmid">21814580</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thunshelle</surname><given-names>C</given-names></name><name><surname>Hamblin</surname><given-names>MR</given-names></name></person-group><article-title>Transcranial low-level laser (light) therapy for brain injury</article-title><source>Photomed Laser Surg.</source><year>2016</year><volume>34</volume><fpage>587</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1089/pho.2015.4051</pub-id><pub-id pub-id-type="pmid">28001759</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>RM</given-names></name><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Bullock</surname><given-names>MR</given-names></name></person-group><article-title>Neurogenesis after traumatic brain injury</article-title><source>Neurosurg Clin N Am.</source><year>2007</year><volume>18</volume><fpage>169</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.nec.2006.10.007</pub-id><pub-id pub-id-type="pmid">17244562</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oron</surname><given-names>U</given-names></name><name><surname>Yaakobi</surname><given-names>T</given-names></name><name><surname>Oron</surname><given-names>A</given-names></name><name><surname>Mordechovitz</surname><given-names>D</given-names></name><name><surname>Shofti</surname><given-names>R</given-names></name><name><surname>Hayam</surname><given-names>G</given-names></name><etal/></person-group><article-title>Low-energy laser irradiation reduces formation of scar tissue after myocardial infarction in rats and dogs</article-title><source>Circulation.</source><year>2001</year><volume>103</volume><fpage>296</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.103.2.296</pub-id><pub-id pub-id-type="pmid">11208692</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>MCP</given-names></name><name><surname>Lo</surname><given-names>SCL</given-names></name><name><surname>Siu</surname><given-names>FKW</given-names></name><name><surname>So</surname><given-names>KF</given-names></name></person-group><article-title>Treatment of experimentally induced transient cerebral ischemia with low energy laser inhibits nitric oxide synthase activity and up-regulates the expression of transforming growth factor-beta 1</article-title><source>Lasers Surg Med.</source><year>2002</year><volume>31</volume><fpage>283</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1002/lsm.10096</pub-id><pub-id pub-id-type="pmid">12355575</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nissan</surname><given-names>M</given-names></name><name><surname>Rochkind</surname><given-names>S</given-names></name><name><surname>Razon</surname><given-names>N</given-names></name><name><surname>Bartal</surname><given-names>A</given-names></name></person-group><article-title>HeNe laser irradiation delivered transcutaneously - its effects on the sciatic nerve of rats</article-title><source>Lasers Surg Med.</source><year>1986</year><volume>6</volume><fpage>435</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1002/lsm.1900060502</pub-id><pub-id pub-id-type="pmid">3807630</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrnes</surname><given-names>KR</given-names></name><name><surname>Waynant</surname><given-names>RW</given-names></name><name><surname>Ilev</surname><given-names>IK</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Barna</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>K</given-names></name><etal/></person-group><article-title>Light promotes regeneration and functional recovery and alters the immune response after spinal cord injury</article-title><source>Lasers Surg Med.</source><year>2005</year><volume>36</volume><fpage>171</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1002/lsm.20143</pub-id><pub-id pub-id-type="pmid">15704098</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lampl</surname><given-names>Y</given-names></name><name><surname>Zivin</surname><given-names>JA</given-names></name><name><surname>Fisher</surname><given-names>M</given-names></name><name><surname>Lew</surname><given-names>R</given-names></name><name><surname>Welin</surname><given-names>L</given-names></name><name><surname>Dahlof</surname><given-names>B</given-names></name><etal/></person-group><article-title>Infrared laser therapy for ischemic stroke: A new treatment strategy results of the NeuroThera effectiveness and Safety Trial-1 (NEST-1)</article-title><source>Stroke.</source><year>2007</year><volume>38</volume><fpage>1843</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.106.478230</pub-id><pub-id pub-id-type="pmid">17463313</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naeser</surname><given-names>MA</given-names></name><name><surname>Hamblin</surname><given-names>MR</given-names></name></person-group><article-title>Traumatic brain injury: a major medical problem that could be treated using transcranial, red/near-infrared LED photobiomodulation</article-title><source>Photomed Laser Surg.</source><year>2015</year><volume>33</volume><fpage>443</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1089/pho.2015.3986</pub-id><pub-id pub-id-type="pmid">26280257</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naeser</surname><given-names>MA</given-names></name><name><surname>Martin</surname><given-names>PI</given-names></name><name><surname>Ho</surname><given-names>MD</given-names></name><name><surname>Krengel</surname><given-names>MH</given-names></name><name><surname>Bogdanova</surname><given-names>Y</given-names></name><name><surname>Knight</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Transcranial, red/near-infrared light-emitting diode therapy to improve cognition in chronic traumatic brain injury</article-title><source>Photomed Laser Surg.</source><year>2016</year><volume>34</volume><fpage>610</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1089/pho.2015.4037</pub-id><pub-id pub-id-type="pmid">28001756</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naeser</surname><given-names>MA</given-names></name><name><surname>Zafonte</surname><given-names>R</given-names></name><name><surname>Krengel</surname><given-names>MH</given-names></name><name><surname>Martin</surname><given-names>PI</given-names></name><name><surname>Frazier</surname><given-names>J</given-names></name><name><surname>Hamblin</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Significant improvements in cognitive performance post-transcranial, red/near-infrared light-emitting diode treatments in chronic, mild traumatic brain injury: open-protocol study</article-title><source>J Neurotrauma.</source><year>2014</year><volume>31</volume><fpage>1008</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1089/neu.2013.3244</pub-id><pub-id pub-id-type="pmid">24568233</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saltmarche</surname><given-names>AE</given-names></name><name><surname>Naeser</surname><given-names>MA</given-names></name><name><surname>Ho</surname><given-names>KF</given-names></name><name><surname>Hamblin</surname><given-names>MR</given-names></name><name><surname>Lim</surname><given-names>L</given-names></name></person-group><article-title>Significant improvement in cognition in mild to moderately severe dementia cases treated with transcranial plus intranasal photobiomodulation: case series report</article-title><source>Photomed Laser Surg.</source><year>2017</year><volume>35</volume><fpage>432</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1089/pho.2016.4227</pub-id><pub-id pub-id-type="pmid">28186867</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haeussinger</surname><given-names>FB</given-names></name><name><surname>Heinzel</surname><given-names>S</given-names></name><name><surname>Hahn</surname><given-names>T</given-names></name><name><surname>Schecklmann</surname><given-names>M</given-names></name><name><surname>Ehlis</surname><given-names>AC</given-names></name><name><surname>Fallgatter</surname><given-names>AJ</given-names></name></person-group><article-title>Simulation of near-infrared light absorption considering individual head and prefrontal cortex anatomy: implications for optical neuroimaging</article-title><source>PloS One.</source><year>2011</year><volume>6</volume><fpage>e26377</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0026377</pub-id><pub-id pub-id-type="pmid">22039475</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karu</surname><given-names>TI</given-names></name></person-group><article-title>Molecular mechanism of the therapeutic effect of low-intensity laser irradiation</article-title><source>Dokl Akad Nauk SSSR.</source><year>1986</year><volume>291</volume><fpage>1245</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">3542462</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>AT</given-names></name><name><surname>Ward</surname><given-names>CH</given-names></name><name><surname>Mendelson</surname><given-names>M</given-names></name><name><surname>Mock</surname><given-names>J</given-names></name><name><surname>Erbaugh</surname><given-names>J</given-names></name></person-group><article-title>An inventory for measuring depression</article-title><source>Arch Gen Psychiatry.</source><year>1961</year><volume>4</volume><fpage>561</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.1961.01710120031004</pub-id><pub-id pub-id-type="pmid">13688369</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>AT</given-names></name><name><surname>Steer</surname><given-names>RA</given-names></name></person-group><source>Beck Anxiety Inventory manual</source><year>1993</year><publisher-loc>San Antonio, TX</publisher-loc><publisher-name>Psychological Corporation</publisher-name></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Spreen</surname><given-names>O</given-names></name><name><surname>Strauss</surname><given-names>E</given-names></name></person-group><source>A compendium of neuropsychological tests administration norms and commentary</source><year>1998</year><publisher-loc>New York, NY</publisher-loc><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuss</surname><given-names>DT</given-names></name><name><surname>Floden</surname><given-names>D</given-names></name><name><surname>Alexander</surname><given-names>MP</given-names></name><name><surname>Levine</surname><given-names>B</given-names></name><name><surname>Katz</surname><given-names>D</given-names></name></person-group><article-title>Stroop performance in focal lesion patients: dissociation of processes and frontal lobe lesion location</article-title><source>Neuropsychologia.</source><year>2001</year><volume>39</volume><fpage>771</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/S0028-3932(01)00013-6</pub-id><pub-id pub-id-type="pmid">11369401</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regard</surname><given-names>M</given-names></name><name><surname>Strauss</surname><given-names>E</given-names></name><name><surname>Knapp</surname><given-names>P</given-names></name></person-group><article-title>Children&#x02019;s production on verbal and non-verbal fluency tasks</article-title><source>Percept Mot Skills.</source><year>1982</year><volume>55</volume><fpage>839</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.2466/pms.1982.55.3.839</pub-id><pub-id pub-id-type="pmid">7162920</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burik</surname><given-names>TE</given-names></name></person-group><article-title>Relative roles of the learning and motor factors involved in the digit symbol test</article-title><source>J Psychol.</source><year>1950</year><volume>30</volume><fpage>33</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1080/00223980.1950.9916049</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLeod</surname><given-names>DR</given-names></name><name><surname>Griffiths</surname><given-names>RR</given-names></name><name><surname>Bigelow</surname><given-names>GE</given-names></name><name><surname>Yingling</surname><given-names>J</given-names></name></person-group><article-title>An automated version of the digit symbol substitution test (DSST)</article-title><source>Behav Res Methods Instrum.</source><year>1982</year><volume>14</volume><fpage>463</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.3758/BF03203313</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="other">Malloy-Diniz LF, Lasmar VA, Gazinelli LdeS, Fuentes D, Salgado JV. The Rey Auditory-Verbal Learning Test: applicability for the Brazilian elderly population. Revista Brasileira De Psiquiatria. 2007;29:324&#x02013;9</mixed-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nascimento</surname><given-names>E</given-names></name><name><surname>Figueiredo</surname><given-names>VL</given-names></name></person-group><source>Escala de Intelig&#x000ea;ncia Weschler para Adultos - manual t&#x000e9;cnico</source><year>2005</year><publisher-loc>S&#x000e3;o Paulo</publisher-loc><publisher-name>Casa do Psic&#x000f3;logo</publisher-name></element-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">Rey A. Figuras complexas de Rey - manual t&#x000e9;cnico. S&#x000e3;o Paulo: Casa do Psicologo; 2010</mixed-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tombaugh</surname><given-names>TN</given-names></name><name><surname>Faulkner</surname><given-names>P</given-names></name><name><surname>Hubley</surname><given-names>AM</given-names></name></person-group><article-title>Effects of age on the Rey-Osterrieth and taylor complex figures - test-retest data using an intentional learning-paradigm</article-title><source>J Clin Exp Neuropsychol.</source><year>1992</year><volume>14</volume><fpage>647</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1080/01688639208402853</pub-id><pub-id pub-id-type="pmid">1474136</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lezak</surname><given-names>MD</given-names></name><name><surname>Howieson</surname><given-names>DB</given-names></name><name><surname>Bigler</surname><given-names>ED</given-names></name><name><surname>Tranel</surname><given-names>D</given-names></name></person-group><source>Neuropsychological assessment</source><year>2012</year><edition>5</edition><publisher-loc>New York</publisher-loc><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>KC</given-names></name></person-group><article-title>Laser (and LED) therapy is phototherapy</article-title><source>Photomed Laser Surg.</source><year>2005</year><volume>23</volume><fpage>78</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1089/pho.2005.23.78</pub-id><pub-id pub-id-type="pmid">15782040</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavery</surname><given-names>LA</given-names></name><name><surname>Murdoch</surname><given-names>DP</given-names></name><name><surname>Williams</surname><given-names>J</given-names></name><name><surname>Lavery</surname><given-names>DC</given-names></name></person-group><article-title>Does anodyne light therapy improve peripheral neuropathy in diabetes? A double-blind, sham-controlled, randomized trial to evaluate monochromatic infrared photoenergy</article-title><source>Diabetes Care.</source><year>2008</year><volume>31</volume><fpage>316</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.2337/dc07-1794</pub-id><pub-id pub-id-type="pmid">17977931</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>JC</given-names></name><name><surname>Bruchey</surname><given-names>AK</given-names></name><name><surname>Gonzalez-Lima</surname><given-names>F</given-names></name></person-group><article-title>Low-level light therapy improves cortical metabolic capacity and memory retention</article-title><source>J Alzheimers Dis.</source><year>2012</year><volume>32</volume><fpage>741</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">22850314</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>JC</given-names></name><name><surname>Gonzalez-Lima</surname><given-names>F</given-names></name></person-group><article-title>Neurological and psychological applications of transcranial lasers and LEDs</article-title><source>Biochem Pharmacol.</source><year>2013</year><volume>86</volume><fpage>447</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2013.06.012</pub-id><pub-id pub-id-type="pmid">23806754</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naeser</surname><given-names>M</given-names></name><name><surname>Ho</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>P</given-names></name><name><surname>Treglia</surname><given-names>EM</given-names></name><name><surname>Krengel</surname><given-names>MH</given-names></name><name><surname>Hamblin</surname><given-names>M</given-names></name><etal/></person-group><article-title>Improved language after scalp application of red/near-infrared light-emitting diodes: pilot study supporting a new, noninvasive treatment for chronic aphasia</article-title><source>Procedia Social and Behavioral Sciences.</source><year>2012</year><volume>61</volume><fpage>138</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.sbspro.2012.10.116</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Andrade</surname><given-names>AF</given-names></name><name><surname>Paiva</surname><given-names>WS</given-names></name><name><surname>de Amorim</surname><given-names>RLO</given-names></name><name><surname>Figueredo</surname><given-names>EG</given-names></name><name><surname>Rusafa Neto</surname><given-names>E</given-names></name><name><surname>Teixeira</surname><given-names>MJ</given-names></name></person-group><article-title>The pathophysiological mechanisms following traumatic brain injury</article-title><source>Rev Assoc Med Bras.</source><year>2009</year><volume>55</volume><fpage>75</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1590/S0104-42302009000100020</pub-id><pub-id pub-id-type="pmid">19360283</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naeser</surname><given-names>MA</given-names></name><name><surname>Hamblin</surname><given-names>MR</given-names></name></person-group><article-title>Potential for transcranial laser or LED therapy to treat stroke, traumatic brain injury, and neurodegenerative disease</article-title><source>Photomed Laser Surg.</source><year>2011</year><volume>29</volume><fpage>443</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1089/pho.2011.9908</pub-id><pub-id pub-id-type="pmid">21728786</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hennessy</surname><given-names>M</given-names></name><name><surname>Hamblin</surname><given-names>MR</given-names></name></person-group><article-title>Photobiomodulation and the brain: a new paradigm</article-title><source>J Opt.</source><year>2017</year><volume>19</volume><fpage>013003</fpage><pub-id pub-id-type="doi">10.1088/2040-8986/19/1/013003</pub-id><pub-id pub-id-type="pmid">28580093</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lapchak</surname><given-names>PA</given-names></name></person-group><article-title>Taking a light approach to treating acute ischemic stroke patients: Transcranial near-infrared laser therapy translational science</article-title><source>Ann Med.</source><year>2010</year><volume>42</volume><fpage>576</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.3109/07853890.2010.532811</pub-id><pub-id pub-id-type="pmid">21039081</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiffer</surname><given-names>F</given-names></name><name><surname>Johnston</surname><given-names>AL</given-names></name><name><surname>Ravichandran</surname><given-names>C</given-names></name><name><surname>Polcari</surname><given-names>A</given-names></name><name><surname>Teicher</surname><given-names>MH</given-names></name><name><surname>Webb</surname><given-names>RH</given-names></name><etal/></person-group><article-title>Psychological benefits 2 and 4&#x000a0;weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety</article-title><source>Behav Brain Funct.</source><year>2009</year><volume>5</volume><fpage>46</fpage><pub-id pub-id-type="doi">10.1186/1744-9081-5-46</pub-id><pub-id pub-id-type="pmid">19995444</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>DW</given-names></name><name><surname>Gonzalez-Lima</surname><given-names>F</given-names></name></person-group><article-title>Transcranial infrared laser stimulation produces beneficial cognitive and emotional effects in humans</article-title><source>Neuroscience.</source><year>2013</year><volume>230</volume><fpage>13</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.11.016</pub-id><pub-id pub-id-type="pmid">23200785</pub-id></element-citation></ref></ref-list></back></article>